Press
Releases

Press Releases

November 22, 2021
Altimmune to Present at Upcoming Investor and Scientific Conferences
GAITHERSBURG, Md. , Nov. 22, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will be presenting virtually at the following conferences: Piper Sandler 33 rd Annual Virtual Healthcare
November 10, 2021
Altimmune to Present at Upcoming Investor Conferences
GAITHERSBURG, Md. , Nov. 10, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will be presenting virtually at the following investor conferences in November 2021 : Stifel’s 2021 Virtual
 

Investor Contact

Will Brown
Chief Financial Officer

Email: wbrown@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe